Pipeline

MicroCures has built a broad pipeline of novel therapeutic programs based on the company’s proprietary cell migration modulation platform.

The company’s cell movement acceleration programs are focused on excisional wound repair, dermal burn repair, corneal burn repair and cavernous nerve repair/regeneration, among others. Earlier-stage cell movement deceleration programs are being developed to combat cancer metastases and fibrosis.

IndicationStatusHighlight 
Excisional Wound RepairLead development program with planned IND filing and initiation of Phase 1 trials in 2020Preclinical studies demonstrated significantly improved speed and quality of tissue repairread more »
Dermal Burn RepairInitiation of tox studies in 1H 2020Preclinical studies demonstrated significantly improved speed and quality of tissue repairread more »
Corneal Burn RepairPreclinical studies ongoingPreclinical studies demonstrated significantly improved tissue repair and ocular functionread more »
Cavernous Nerve RegenerationPreclinical studies ongoingPreclinical studies demonstrated significantly improved erectile responseread more »
Spinal Cord RegenerationPreclinical studies ongoingPreclinical studies demonstrated significantly improved movement and functionread more »
Cardiac Tissue RepairPreclinical studies ongoingPreclinical studies demonstrated significantly improved tissue repair and cardiac functionread more »